MedPath

Outcomes following emergency surgery for patients with head injury

Not Applicable
Conditions
Health Condition 1: G89-G99- Other disorders of the nervous systemHealth Condition 2: S068- Other specified intracranial injuries
Registration Number
CTRI/2019/02/017479
Lead Sponsor
ational Institute for Health Research NIHR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Hospital inclusion criteria

Any hospital or clinic worldwide performing emergency surgery for traumatic brain injury is eligible to participate. NIMHANS complies to this criterion fully.

Core Study patient inclusion and exclusion criteria

Inclusion criteria

All adult and paediatric patients admitted to NIMHANS with a traumatic brain injury for which they receive emergency surgery during the selected 30-day inclusion period are eligible for inclusion in the core study.

Exclusion Criteria

Patients who only have an external ventricular drain or intraparenchymal wire (or other monitoring device) inserted for the diagnosis and/or management of intracranial hypertension.

ï?· Patients who undergo procedures for chronic subdural haematoma(s), including burr holes or mini-craniotomies.

ï?· Elective (planned admission) or semi-elective (where patient initially admitted as an emergency, then discharged from hospital, and re-admitted at later time for surgery) procedures.

ï?· Patients who have previously had emergency cranial surgery for traumatic brain injury rendering them eligible for inclusion in this study (regardless of whether they were included)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
14-day mortalityTimepoint: 14-day mortality
Secondary Outcome Measures
NameTimeMethod
Return to operating theatre during follow up period <br/ ><br>ï?· Length of stay in hospital <br/ ><br>ï?· Length of stay in intensive care <br/ ><br>ï?· Glasgow Coma Score at discharge (GOS-D)Timepoint: At discharge, during 14 day follow up period
© Copyright 2025. All Rights Reserved by MedPath